Skip to main content

Nisha Ohri, MD

Division of Clinical Radiation Oncology

I am a Radiation Oncologist who specializes in the treatment of patients with breast cancer. Before joining the Stacy Goldstein Breast Cancer Center at Rutgers Cancer Institute of New Jersey, I completed residency training in New York City at the Icahn School of Medicine at Mount Sinai. Prior to this, I graduated Summa Cum Laude from the School of Engineering and Applied Sciences at Columbia University, followed by medical school at the Columbia University College of Physicians and Surgeons. As part of a multidisciplinary team that provides comprehensive treatment to patients with breast cancer, it is my goal to provide individualized and compassionate care to all my patients. Working at a National Cancer Institute-designated Comprehensive Cancer Center, I have access to the latest technology that can effectively deliver radiation treatment while minimizing long-term side effects. In addition to treating patients with breast cancer, I am certified in Gamma Knife Radiosurgery for the treatment of malignant and non-malignant cancers of the brain. I remain actively involved in clinical breast cancer research and have published multiple peer-reviewed articles and text book chapters focused on various aspects of breast cancer management. I also presented my research at the national meeting of the American Society for Radiation Oncology (ASTRO) and am involved in education for residents training in the field of radiation oncology.



  1. Sayan M, Yehia ZA, Ohri N, Haffty BG; Hypofractionated Postmastectomy Radiation Therapy; Advances in Radiation Oncology, Volume 6, Issue 1: 100618, Jan 2021.
  2. Jhawar SR, Alpert N, Taioli E, Sayan M, Bazan J, Park KU, Stover D, Cherian M, White J, Haffty BG, Ohri N; Adjuvant Radiation Therapy Alone is Associated with Improved Overall Survival Compared to Hormonal Therapy Alone in Older Women with Estrogen Receptor Positive Early Stage Breast Cancer; Cancer Medicine, Volume 9, Issue 22: 8345-8354, Nov 2020.
  3. Sayan M, Vergalasova I, Jhawar S, Kumar S, George M, Kowzun M, Potdevin L, Toppmeyer D, Haffty BG, Ohri N; Utilization of Hypofractionated Whole Breast Radiotherapy with Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy; Clinical Breast Cancer, June 2020.
  4. Ohri N, Haffty BG; The Evolution of Adjuvant Radiation Therapy for Early-Stage and Locally Advanced Breast Cancer; Breast Journal, Volume 26, Issue 1: 59-64, Jan 2020.
  5. Sayan M, Yehia ZA, Gupta A, Toppmeyer D, Ohri N, Haffty BG; Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients; Frontiers in Oncology, eCollection, Oct 2019.
  6. Ohri N, Haffty BG; Mastectomy First, Keeping Chemotherapy and Radiation in Reserve; International Journal of Radiation Oncology, Biology, Physics, Volume 105, Issue 1: 20, Sep 2019.
  7. Gupta A, Ohri N, Haffty BG; Hypofractionated Radiation Treatment in the Management of Breast Cancer; Expert Review of Anticancer Therapy, Volume 18, Issue 8:793-803, Aug 2018.
  8. Ohri N, Haffty BG; Is There a Role for Postmastectomy Radiation (PMRT) in Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Treated in the Modern Era? Ann Surg Oncol, Volume 25, Issue 7: 1788-1790, July 2018.
  9. Ohri N, Haffty BG, Buchholz TA; The Role of Postmastectomy Radiotherapy in Patients with Stage II Breast Cancer; Cancer, Volume 124, Issue 3: 450-452, Feb 2018.
  10. Ohri N, Moshier E, Ho A, Green S, Rhome R, Mazumdar M, Powell S, Tsai CJ; Postmastectomy Radiation in Breast Cancer Patients with Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends; International Journal of Radiation Oncology, Biology, Physics, Volume 99, Issue 3: 549-559, June 2017.